Boyd Biomedical, Inc.

© 2026 Boyd Biomedical, Inc.

DISCIPLINES

Market Access

Regulatory clearance opens the market, but payment and purchase decisions determine adoption. We help you build the path to payment and purchase, so clearance translates into coverage, contracts, and revenue.

×

Please feel out the form below and someone from our team will contact you shortly.
disciplines_LBB_market-access_color_800x800
Overview

Market access defines how your device will be reimbursed, priced, and purchased. We help biomedical innovators build the coding, coverage, and economic case that payers, health systems, and value analysis committees require. Planned before submission, market access shortens the time between clearance and revenue.

What market access covers

Market access turns a cleared device into one that is purchased and paid for. Our work helps you secure reimbursement, establish a defensible price, and demonstrate value to the stakeholders who approve the purchase.

  • Reimbursement

    Coding, coverage, and payment strategies, with payer engagement to secure reimbursement.

  • Pricing

    Pricing set and tested against the market, with a contracting approach grounded in real cost of goods.

  • Health Economics

    Budget impact, cost, and economic value models that demonstrate value to payers and health systems.

  • Health System Access

    Strategies for hospitals, IDNs, GPOs, value analysis committees, and site-of-care decisions.

Where market access shows up

Market access should begin well before submission, because reimbursement and pricing decisions shape the evidence plan, the business model, and the launch timeline. It leads from Pivotal Development through Market Clearance and continues to expand coverage as the device grows.

PHASE 0

Foundation

Supports early reimbursement landscape and pricing assumptions.

PHASE 1

Clinical Evidence

Supports identifying the economic data payers will require.

PHASE 2

Pivotal Development

Leads reimbursement, health economics, and pricing strategy.

PHASE 3

Regulatory Submission

Leads coding, coverage, payment, and value analysis strategy.

PHASE 4

Market Clearance

 Leads payer engagement, pricing, and contracting. 

PHASE 5

Commercial Launch

Supports value analysis reviews and health system contracting.

PHASE 6

Growth

Leads payer coverage expansion and contract renewals.

The ROI on better market access

A device that isn’t reimbursed won’t be adopted. Early market access planning reduces the gap between clearance and revenue, and positions you at launch with the economic case buyers expect.

Clear Path to Reimbursement

Coding, coverage, and payment strategies in place before launch.

Defensible Pricing

Pricing supported by economic value and real cost of goods.

Faster Purchasing Decisions

Value analysis and contracting strategies that shorten the sales cycle.

Faster Time to Revenue

Less time between clearance and the first paid procedure.

Explore our disciplines

Every program draws on a different combination of our core disciplines to build the path from innovation to adoption.

  • disciplines_LBB_evidence-insights_mono_800x800

    Evidence & Insights

    Ground commercial decisions in what clinicians, payers, and buyers need to see.

  • disciplines_LBB_go-to-market_mono_800x800

    Go-to-Market

    Turn strategy into launch plans and marketing programs that drive adoption.

  • disciplines_LBB_commercial-strategy_mono_800x800

    Commercial Strategy

    Choose the right market, define a differentiated position, and confirm the opportunity justifies the investment

  • disciplines_LBB_market-access_mono_800x800

    Market Access

    Build the path to payment and purchase, from coding and coverage to contracts.

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your strategy up to the task? We help you turn Just Might into Just Mighty.